Astera Labs (NASDAQ:ALAB) Research Coverage Started at Royal Bank Of Canada

Royal Bank Of Canada started coverage on shares of Astera Labs (NASDAQ:ALAB) in a research note released on Wednesday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $225.00 price objective on the stock.

Other equities research analysts have also issued research reports about the stock. Roth Capital raised their price target on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Citigroup reiterated an “outperform” rating on shares of Astera Labs in a research note on Tuesday, December 9th. Wall Street Zen lowered shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Bank of America assumed coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price objective for the company. Finally, JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $190.63.

Astera Labs Stock Performance

ALAB opened at $182.00 on Wednesday. The company has a market capitalization of $30.74 billion, a P/E ratio of 163.96, a PEG ratio of 2.38 and a beta of 1.50. Astera Labs has a 1-year low of $47.13 and a 1-year high of $262.90. The company has a 50-day moving average of $159.80 and a 200-day moving average of $165.75.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same period in the prior year, the company earned $0.23 earnings per share. The business’s revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts expect that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 90,459 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at $231,467,827.50. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Philip Mazzara sold 4,620 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the transaction, the general counsel directly owned 147,040 shares in the company, valued at $21,275,217.60. This trade represents a 3.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 576,936 shares of company stock valued at $87,409,540. 12.50% of the stock is owned by corporate insiders.

Institutional Trading of Astera Labs

Several large investors have recently made changes to their positions in the company. Royal Bank of Canada increased its holdings in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its position in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in Astera Labs in the 2nd quarter valued at $431,000. Finally, Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs during the 2nd quarter valued at $29,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.